← Eichor
Condition: Gout Arthritis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Gout Arthritis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares
Phase 4 · 1 location(s) · Massachusetts General Hospital · NCT07346079Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets
Phase 4 · 1 location(s) · Huashan Hospital · NCT06966635Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration
Phase 3 · 6 location(s) · University Hospital, Rouen · NCT05109936Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Phase N/A · 1 location(s) · University of Bonn · NCT07150000Nurse-Led Telehealth for Gout
NA · 5 location(s) · University of Aarhus · NCT06971146the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More
Phase 4 · 1 location(s) · Seoul National University Hospital · NCT06622603SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial
Phase 4 · 1 location(s) · Massachusetts General Hospital · NCT06674109A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout.
Phase 1 · 1 location(s) · Shanghai Institute Of Biological Products · NCT06298071Effect of Dotinurad in Hyperuricemia With Hypertension
Phase 4 · 1 location(s) · Saga University · NCT06834230A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
Phase 2 · 17 location(s) · Crystalys Therapeutics · NCT07535034A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens,
Phase 2 · 27 location(s) · Protalix · NCT07280156Tight Control of Gouty Arthritis Compared to Usual Care
NA · 1 location(s) · University of Edinburgh · NCT05507723CRYSTALILLE Cohort: Getting the Whole Picture of Crystal-related Arthropathies
Phase N/A · 1 location(s) · Lille Catholic University · NCT04695028Metformin in Safety and Efficacy in Gouty Patients
Phase 2 · 1 location(s) · Mostafa Bahaa · NCT06924658Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
Phase 4 · 7 location(s) · Massachusetts General Hospital · NCT04875702Time Required to Dissolve Urate Deposits
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06669000Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia
NA · 1 location(s) · OMNIFARMA LLC · NCT07002762Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Phase 2 · 38 location(s) · Atom Therapeutics Co., Ltd · NCT07145229Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Sy
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT05927688Tigulixostat (IBI128) vs Febuxostat in Gout
Phase 3 · 1 location(s) · Innovent Biologics Technology Limited (Shanghai R&D Center) · NCT07414394A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With
Phase 2 · 1 location(s) · TJ Biopharma Co., Ltd. · NCT07453004Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With Gout
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05546593Drug-Drug Interaction Study of ABP-671 in Gout Patients
Phase 1 · 1 location(s) · Atom Therapeutics Co., Ltd · NCT07367971Dose Response of Exercise for Arthritis Management
NA · 1 location(s) · University of South Carolina · NCT06880653Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis
Phase 3 · 1 location(s) · Laboratorios Silanes S.A. de C.V. · NCT06863701Improving Gout Care After an ED Visit
NA · 1 location(s) · University of Alabama at Birmingham · NCT06534554Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia
Phase 1 · 1 location(s) · Shenyang Sunshine Pharmaceutical Co., LTD. · NCT06629376The Remote Monitoring of Gout Feasibility Study in Primary Care
NA · 1 location(s) · Diakonhjemmet Hospital · NCT07490522Comparative Clinical and Biochemical Study Evaluating the Effectiveness of Metformin Versus Febuxostat on Gouty Obese No
Phase 2 · 1 location(s) · Mostafa Bahaa · NCT06995339The Orienting Study
Phase N/A · 1 location(s) · I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · NCT07504146
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.